About Vascular Perfusion
Vascular Perfusion is a company based in San Antonio (United States) founded in 2016 by Tom DeBrooke. Vascular Perfusion has raised $151.67 million across 6 funding rounds. Vascular Perfusion offers products and services including VP.S ENCORE®. Vascular Perfusion operates in a competitive market with competitors including TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and ADVITOS, among others.
- Headquarter San Antonio, United States
- Founders Tom DeBrooke
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Vascular Perfusion Solutions, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$151.67 M (USD)
in 6 rounds
-
Latest Funding Round
$147.02 M (USD), Series D
May 16, 2025
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vascular Perfusion
Vascular Perfusion offers a comprehensive portfolio of products and services, including VP.S ENCORE®.
Medical device for preserving organs during transplantation processes.
People of Vascular Perfusion
Unlock access to complete
Funding Insights of Vascular Perfusion
Vascular Perfusion has successfully raised a total of $151.67M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $147.02 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Vascular Perfusion
Investment portfolio details for Vascular Perfusion
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vascular Perfusion
Detailed financials for Vascular Perfusion
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vascular Perfusion Comparisons
Peer comparison for Vascular Perfusion
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vascular Perfusion
Vascular Perfusion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Paragonix Technologies, Bridge to Life and ADVITOS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of organ transplantation technology
|
|
| Locked | Locked | Locked |
Warm storage and transport systems for harvested organs are provided.
|
|
| Locked | Locked | Locked |
Organ preservation and transport systems are developed for transplants.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Multi-organ support systems for liver, lung, and kidney are provided.
|
Detailed competitors of Vascular Perfusion
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vascular Perfusion
Complete news archive for Vascular Perfusion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vascular Perfusion
Vascular Perfusion was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Vascular Perfusion is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Tom DeBrooke is the current CEO of Vascular Perfusion. They have also founded this company.
Vascular Perfusion is a funded company, having raised a total of $151.67M across 6 funding rounds to date.
Vascular Perfusion was founded in 2016 in San Antonio, United States, within the medical device sector focused on organ transplantation. Operations center on the development of the VP.S ENCORE device, which aims to prolong organ viability outside the body. This addresses rejection issues caused by transportation delays, surpassing the standard ice-cooling preservation method. The companys efforts target improvements in transplant therapy accessibility.
Vascular Perfusion's top competitors include TransMedics, OrganOx and ADVITOS.
Vascular Perfusion offers VP.S ENCORE®.